French medical technology startup, Sonio, has raised $14 million in Series A funding, bringing its total funding to $20 million since its founding in 2020. Sonio’s AI platform automates ultrasound reporting, aiming to improve accuracy, speed, and efficiency for healthcare providers. The platform receives ultrasound images from any machine and processes them in the cloud to provide real-time analysis with an accuracy rate of at least 95% for identifying potential prenatal syndromes and anomalies. Sonio’s platform also includes a clinical decision support tool that prioritizes potential rare diagnoses based on text-based clinical databases. The company sells its software to hospitals, women’s health groups, and private physician practices on a monthly or yearly subscription basis. Sonio intends to use the new funding to expand its team and begin commercial development in the United States. Although the technology has been cleared for use in Europe, it has not yet received FDA clearance.
July 13, 2023
Artificial Intelligence
FDAcop
